The Centers for Disease Control and Prevention today released the first module in a new  to help clinicians apply its  for adults with chronic pain. The first module presents an overview of the guidelines. Future modules are expected to address: communicating with patients; treating chronic pain without opioids; deciding whether to prescribe opioids; opioid dosing and titration; reducing opioid risks; assessing and addressing opioid use disorder; and implementing the guidelines in the practice.

Related News Articles

Headline
A new initiative launched March 18 by the Dr. Lorna Breen Heroes' Foundation seeks to improve mental health care access for health care workers. The program,…
Headline
A study published Feb. 26 by JAMA Psychiatry found that female physicians died by suicide at more than 1.5 times the rate of female nonphysicians from 2017-…
Headline
The AHA voiced support for bipartisan House legislation introduced Feb. 4 to reauthorize for five years the Dr. Lorna Breen Health Care Provider Protection Act…
Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
The AHA Jan. 28 voiced support for bipartisan legislation to reauthorize for five years the Dr. Lorna Breen Health Care Provider Protection Act, which provides…
Headline
Perinatal mental health disorders affect countless mothers during pregnancy and postpartum, yet access to comprehensive care remains a challenge. Hospitals are…